What Researchers Did
Researchers tested whether hyperbaric oxygen therapy (HBOT) reduces the need for major amputation and improves wound healing in people with diabetes and long-lasting foot ulcers.
What They Found
In this double-blind randomized controlled trial of patients with diabetes and chronic foot ulcers, HBOT did not reduce the number of patients meeting criteria for major amputation compared with sham treatment (11 of 49 versus 13 of 54; odds ratio 0.91, 95% CI 0.37 to 2.28, p = 0.846). Of 157 patients assessed, 107 were randomly assigned and 103 were available for the final assessment at 12 weeks. Healing occurred in 10 patients (20%) in the HBOT group and 12 (22%) in the sham group (p = 0.823). All other wound healing measures were also not statistically significantly different between groups.
What This Means for Canadian Patients
For adults with diabetes and chronic foot ulcers, this trial found that HBOT added to comprehensive wound care did not offer an additional advantage in reducing the indication for amputation or helping wounds heal. The treatment was 30 daily sessions of 90 minutes of oxygen at 244 kPa, compared with sham sessions of air at 125 kPa. Patients considering HBOT for a diabetic foot ulcer can discuss these results with their care team.
Canadian Relevance
The abstract does not name the study location, but the study is indexed as having a Canadian connection.
Study Limitations
The abstract reports that 4 of the 107 randomized patients were not available for final assessment, and it does not describe other limitations, so the results apply only to the 12-week outcomes in this group of patients.